/Lilly(Eli)%20%26%20Co%20logo%20on%20building-by%20Michael%20Vi%20via%20Shutterstock.jpg)
Eli Lilly (LLY) shares closed comfortably in the green on Thursday as strong GLP-1 sales helped the pharmaceutical behemoth report a blockbuster Q1 and raise guidance for the full year.
According to the earnings release, LLY’s combined revenue from Zepbound and Mounjaro more than doubled year-over-year to $12.82 billion in the first quarter.